Posts

Beyond Antidepressants: Exploring the Safe Tapering Process and Neurotherapies for Mental Wellness

Image
Beyond Antidepressants: Exploring the Safe Tapering Process and Neurotherapies for Mental Wellness By Charles Miller, CRNA, CMO, Founder of Scenic City Neurotherapy Deciding to taper off antidepressants is a significant and deeply personal decision. While antidepressants can be lifesaving for many individuals, there may come a point when you feel ready to move forward without them. Whether it’s because of side effects, a desire to explore alternative therapies, or simply reaching a point in your mental health journey where medication no longer feels necessary or aligned with your goals, the process of tapering off requires thoughtful planning and support.  In this blog, we’ll explore the tapering process, the role of professional guidance, and how Neurotherapies like Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) and Transcranial Magnetic Stimulation (TMS) can assist in making this journey a success.   Understanding Antidepressants and Their Role Our  “The Impact...

Minimum Requirements For A Ketamine Infusion Center

Image
Minimum Requirements For A Ketamine Infusion Center By Charles Miller, CRNA, CMO, Founder of Scenic City Neurotherapy Ensuring a safe and effective ketamine infusion experience is crucial to achieving positive patient outcomes. Over the past five years, Scenic City Neurotherapy has meticulously reviewed extensive literature on ketamine infusion therapy and its physiological impacts in treating mental health, chronic pain, and other neuro-degenerative conditions. Scenic City Neurotherapy’s approach,  Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) , utilizes optimal administration, modality, dosing, and duration, all grounded in extensive research from the fields of anesthesia and psychiatry. This tailored process is designed to maximize long-term improvements in cognition, functionality, and mood regulation, offering patients the best possible outcomes. This blog explores the foundational elements necessary for ketamine infusion centers to uphold rigorous standards of care....

Why New Year’s Resolutions Fail: A Neuroscience and Psychological Perspective

Image
  Why New Year’s Resolutions Fail: A Neuroscience and Psychological Perspective By Charles Miler, CRNA, CMO, Founder of Scenic City Neurotherapy   As the new year approaches, people everywhere feel excited and motivated to set fresh goals, often known as New Year’s resolutions. But as quickly as this enthusiasm arises, it tends to fade—most resolutions fail by February. The question is: why? This blog will explore the reasons behind these failures from a neuroscience and psychological standpoint and how treatments like Minimally Stimulated Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) and Transcranial Magnetic Stimulation (TMS) can help provide support.   The Neuroscience of Habit Formation Brain Chemistry and Habits Habit Formation:  Understanding how the brain works can illuminate why making lasting changes is so complex. Habits are stored in a part of the brain called the basal ganglia, which is responsible for automating behaviors. Meanwhile, the prefro...

TMS vs. ECT: A Comprehensive Guide to Advanced Depression Treatment Options

Image
Katherine Kessler Written by Katherine Kessler  When it comes to treating severe depression and other mental health disorders, two prominent treatment options often come into consideration: Transcranial Magnetic Stimulation (TMS) and Electroconvulsive Therapy (ECT). Both therapies have shown significant effectiveness for individuals who have not responded to traditional treatments like medication or psychotherapy. However, while they share some similarities, TMS and ECT differ considerably in their mechanisms, side effects, and patient experiences. This blog will explore the key differences between these two treatments, providing a comprehensive understanding for those considering either option. Introduction To TMS and ECT The  National Institute of Mental Health  estimates that over one in five U.S. adults, about 59.3 million people in 2022, experience mental illness. With the growing interest in advanced treatments for mood disorders, TMS and ECT have emerged as effecti...